Prof. Dr. Guangwen Li,The Affiliated Hospital of Qingdao University, China
Dr. Guangwen Li is the Chief of the Neurology Department at The Affiliated Hospital of Qingdao University, where he leads with distinction in both clinical care and translational neuroscience research. Holding an MD and PhD, Dr. Li has built an exemplary career focused on the basic and clinical study of cerebrovascular diseases, with over 58 publications, 5 published books, and 2 patents to his credit. He is recognized not only as a researcher but also as an academic leader and thought partner in stroke and neurovascular care.
Profile
Orcid
🎓 Early Academic Pursuits
Dr. Li’s journey in medicine began with a rigorous academic foundation, culminating in a PhD in Neurology, where he focused on vascular pathology and brain repair mechanisms. From his early years, he demonstrated a strong interest in stroke research, particularly mechanisms underlying ischemic injury and recovery, which laid the groundwork for his future scientific inquiries.
🧑💼 Professional Endeavors
In his current role as Chief of Neurology, Dr. Li is not only a clinician but also a dedicated academic. He oversees clinical neurology services, mentors early-career researchers, and directs multi-disciplinary stroke research projects. His active roles as Associate Editor and Editorial Board Member across journals like Frontiers in Neuroscience, JNIS, and Clinical Neuroscience Research reflect his broad influence in scientific publishing and peer review.
🧠 Contributions and Research Focus
Dr. Li’s research primarily explores ischemic stroke, with special attention to the neuroinflammatory response, non-coding RNAs, and endovascular intervention timing. His landmark contributions include:
-
Exploring the role of neutrophil-mediated inflammatory pathways in stroke pathology.
-
Defining the optimal therapeutic window for endovascular treatment in intracranial atherosclerotic stenosis.
-
Investigating the lncRNA H19/miRNA-29b axis and its effect on the blood-brain barrier in stroke.
These studies position him at the forefront of neurovascular medicine and post-stroke neurorepair.
🌍 Impact and Influence
With 58 peer-reviewed publications indexed in SCI and Scopus, a citation index of 28, and key involvement in five major research projects, Dr. Li’s work is steadily shaping the direction of modern stroke therapy and translational neurobiology. His role in multiple collaborative projects underscores his commitment to interdisciplinary and cross-institutional research.
📊 Academic Citations
Although currently holding a citation index of 28, Dr. Li’s publication rate and the emerging relevance of his research areas suggest that his academic influence is on a rising trajectory. His novel insights into neuroprotection and gene regulation in stroke have the potential for greater international citation and recognition in the coming years.
🧪 Research Skills
Dr. Li is proficient in a range of molecular, cellular, and translational neuroscience techniques, including:
-
lncRNA and miRNA functional analysis
-
Stroke modeling in vivo
-
Endovascular procedural studies
-
Exosomal biomarker research
His research showcases a strong integration of laboratory science with clinical application, making his approach highly translational and impactful.
👨🏫 Teaching Experience
In addition to his clinical and research leadership, Dr. Li is an active educator, mentoring residents, PhD candidates, and junior faculty in clinical neurology, stroke management, and research methodology. His involvement in curriculum development and neurology training programs adds further value to his institution and students.
🏅 Awards and Honors
While specific honors are not listed, Dr. Li’s editorial appointments, professional memberships, and selection to elite research boards—such as Neural Regeneration Research and Frontiers in Neurology—highlight his academic recognition and leadership stature in the neuroscience community.
🔬 Legacy and Future Contributions
Dr. Guangwen Li is poised to leave a lasting legacy in stroke care and neurovascular research. His future goals likely include:
-
Expanding international collaborations
-
Translating bench findings into bedside therapies
-
Developing precision medicine approaches for stroke rehabilitation
With his current momentum, Dr. Li is well-positioned to influence policy, clinical protocols, and medical education in neurology on a global scale.
Publications
-
Submaximal versus aggressive angioplasty with drug-coated balloons for symptomatic intracranial arterial stenosis
Authors: Guangwen Li, Yayue Liu, Xiaofei Sun, Yujie Sun, Peng Liu, Xianjun Zhang, Xie Anmu, Yong Zhang
Journal: Journal of NeuroInterventional Surgery
Year: 2025
-
Has collateral blood flow any effect on restenosis rate? Our experience
Authors: Li Y, Sun Y, Liu T, Liu P, Li G, Zhang Y
Journal: Frontiers in Neurology
Year: 2024
-
Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial
Authors: Guangwen Li, Yujie Sun, Tonghui Liu, Pengfei Yang, Ya Peng, Wenhuo Chen, Liyong Zhang, Jianfeng Chu, Dong Kuai, Zibo Wang et al.
Journal: BMJ Open
Year: 2023
-
MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
Authors: Xiaoqing Ma, Ho Jun Yun, Kenneth Elkin, Yunlneuroprotectioniang Guo, Yuchuan Ding, Guangwen Li, Feng Zhang
Journal: Mediators of Inflammation
Year: 2022
-
MicroRNA-193a-5p Rescues Ischemic Cerebral Injury by Restoring N2-Like Neutrophil Subsets
Authors: Han Z, Li L, Zhao H, Xiaogang Wang, Yan F, Tao Z, Fan J, Zheng Y, Zhao F, Huang Y et al.
Journal: Translational Stroke Research
Year: 2022